abstract |
A secondary cataract inhibitor containing as the active ingredient N-(3,4-dimethoxycinnamoyl)-anthranilic acid represented by formula (I) or pharmacologically acceptable salts thereof: efficacious in inhibiting, for example, posterior capsular turbidity after cataractal operation and useful for preventing or curing secondary cataract. |